200
Participants
Start Date
June 3, 2019
Primary Completion Date
August 31, 2021
Study Completion Date
October 26, 2021
Rozanolixizumab
Rozanolixizumab will be administered by subcutaneous infusion in dosage regimen 1 or 2.
Placebo
Subjects will receive placebo at pre-specified time points.
Mg0003 50077, New York
Mg0003 50096, Philadelphia
Mg0003 50089, Philadelphia
Mg0003 50088, Washington D.C.
Mg0003 50090, Winston-Salem
Mg0003 50117, Charlotte
Mg0003 50086, Charlotte
Mg0003 50084, Charleston
Mg0003 50075, Augusta
Mg0003 50122, Miami
Mg0003 50120, Miami
Mg0003 50073, Tampa
Mg0003 50121, Lexington
Mg0003 50076, Columbus
Mg0003 50114, Indianapolis
Mg0003 50110, Ann Arbor
Mg0003 50102, Detroit
Mg0003 50104, Rochester
Mg0003 50109, Chicago
Mg0003 50105, St Louis
Mg0003 50074, Fairway
Mg0003 50113, Houston
Mg0003 50101, Aurora
Mg0003 50081, Phoenix
Mg0003 50082, Scottsdale
Mg0003 50072, Los Angeles
Mg0003 50092, Orange
Mg0003 50097, San Francisco
Mg0003 50099, San Francisco
Mg0003 50323, Honolulu
Mg0003 40121, Brussels
Mg0003 50067, Calgary
Mg0003 50066, Montreal
Mg0003 50070, Québec
Mg0003 50069, Toronto
Mg0003 40125, Ostrava
Mg0003 40124, Prague
Mg0003 40128, Aalborg
Mg0003 40127, Aarhus N
Mg0003 40126, Copenhagen
Mg0003 40489, Odense
Mg0003 40129, Bordeaux
Mg0003 40070, Clermont-Ferrand
Mg0003 40512, Garches
Mg0003 40510, Le Kremlin-Bicêtre
Mg0003 40360, Limoges
Mg0003 40426, Lyon
Mg0003 40130, Marseille
Mg0003 40017, Nantes
Mg0003 40132, Nice
Mg0003 40133, Paris
Mg0003 40131, Strasbourg
Mg0003 20160, Tbilisi
Mg0003 20161, Tbilisi
Mg0003 20163, Tbilisi
Mg0003 20165, Tbilisi
Mg0003 40134, Essen
Mg0003 40140, Göttingen
Mg0003 40135, Gummersbach
Mg0003 40139, Jena
Mg0003 40078, Leipzig
Mg0003 40177, Münster
Mg0003 40082, Kistarcsa
Mg0003 40178, Nyíregyháza
Mg0003 40283, Bologna
Mg0003 40149, Lazio
Mg0003 40144, Milan
Mg0003 40307, Napoli
Mg0003 40146, Pavia
Mg0003 40148, Roma
Mg0003 40150, Roma
Mg0003 20035, Bunkyō City
Mg0003 20068, Chiba
Mg0003 20078, Hanamaki-Shi
Mg0003 20079, Hiroshima
Mg0003 20075, Kobe
Mg0003 20071, Nagasaki
Mg0003 20074, Ōsaka-sayama
Mg0003 20067, Sapporo
Mg0003 20077, Sendai
Mg0003 20070, Shinjuku-Ku
Mg0003 20076, Shinjuku-Ku
Mg0003 20032, Suita
Mg0003 40155, Gdansk
Mg0003 40154, Lodz
Mg0003 40151, Lublin
Mg0003 40153, Poznan
Mg0003 20168, Krasnoyarsk
Mg0003 20027, Moscow
Mg0003 20169, Novosibirsk
Mg0003 20001, Saint Petersburg
Mg0003 20028, Saint Petersburg
Mg0003 20029, Saint Petersburg
Mg0003 20055, Saint Petersburg
Mg0003 20197, Samara
Mg0003 40468, Belgrade
Mg0003 40467, Niš
Mg0003 40159, Barcelona
Mg0003 40160, Barcelona
Mg0003 40267, Barcelona
Mg0003 40157, L'Hospitalet de Llobregat
Mg0003 40161, Madrid
Mg0003 40162, Madrid
Mg0003 40341, Málaga
Mg0003 40350, Murcia
Mg0003 40308, San Sebastián de los Reyes
Mg0003 20080, Taichung
Mg0003 20081, Taipei
Mg0003 20086, Taipei
Mg0003 20082, Taoyuan District
Mg0003 40175, London
Mg0003 40168, Nottingham
UCB Biopharma SRL
INDUSTRY